Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Clinical trial NCT01726075 · COMPLETED
Trial details
- NCT number
- NCT01726075
- Sponsor
- BCN Peptides
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-11-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.